[PDF] from viraled.comP Pockros, D Jensen, N Tsai, RM Taylor… - 46th EASL Annual …, 2011 - viraled.com P. Pockros, D. Jensen, N. Tsai, RM Taylor, A. Ramji, CL Cooper, R. Dickson, A. Tice, S. Stancic, D. Ipe, I. Najera, JA Thommes, JM Vierling ... 46th EASL Congress, Berlin, Germany March 30-April 3, 2011 Abstract 1359 ... • Mericitabine (RG7128, MCB) is a potent, ... Cited by 4 - Related articles - View as HTML
HS Pentikis, M Matson, G Atiee… - Antimicrobial Agents …, 2011 - Am Soc Microbiol ... Page 2. 2 ABSTRACT 1 FV-100 is the prodrug of the highly potent anti-varicella zoster virus bicyclic 2 nucleosideanalogue CF-1743. To characterize the pharmacokinetics and safety of 3 oral FV-100, 3 randomized, double-blind, placebo-controlled clinical trials were 4 ... Related articles - All 2 versions
L Enomoto, PL Anderson, S Li… - AIDS Research and …, 2011 - liebertonline.com Abstract Nucleoside analog reverse transcriptase inhibitors (NRTIs) constitute the most commonly used drugs in antiretroviral therapy. NRTIs differ with respect to their host cell toxicity. We compared the in vitro effect of zidovudine (AZT; 2 μg/ml), lamivudine (3TC; 5 ... Related articles - All 2 versions
E Paintsil, GE Dutschman, R Hu… - Antimicrobial Agents …, 2011 - Am Soc Microbiol Individual variation in response to antiretroviral therapy is well-known, but it is not clear if demographic characteristics such as gender, age, and ethnicity are responsible for the variation. To optimize anti-HIV therapy and guide antiretroviral drug discovery, determinants that cause variable ... Related articles - All 3 versions
[CITATION] 1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH …
P Pockros, D Jensen, N Tsai, RM Taylor… - Journal of …, 2011 - Elsevier
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
